We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The drug was originally approved in October 2017 as the first extended-release intra-articular therapy for patients with osteoarthritis-related knee pain. Read More
A group of consumers filed a class action suit against Pfizer, alleging that the company knew or should have known that its over-the-counter heartburn drug Zantac (ranitidine) was contaminated with dangerous levels of NDMA and unsafe for consumption. Read More
Allergan reached a $300 million settlement to resolve a class action lawsuit over the oral contraceptives Loestrin 24 Fe (norethindrone acetate, ethinyl estradiol, and ferrous fumarate) and Minastrin 24 Fe (norethindrone acetate and ethinyl estradiol/ferrous fumarate). Read More